Major update for anyone with type 2 diabetes: A new study says drugs like Ozempic and Wegovy (GLP-1 receptor agonists) might actually beat out the old standby, Metformin, when it comes to controlling blood sugar. SGLT-2 inhibitors also did well, especially for heart health. But DPP-4 inhibitors? Not so much. If you or someone you know is managing diabetes, it might be time to ask the doc about these newer options! #Health #BodyHealth #DiabetesCare